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Health statusPurpose: To compare the effect of high intensity interval training (HIIT) and moderate intensity continuous
training (MICT) on physical ﬁtness and quality of life (QoL) in patients with chronic heart failure (CHF).
Methods: Twenty-two male CHF patients (LVEF b 45%, mean age 53.8 ± 8 yr) were studied before and after
12 weeks of supervised aerobic training for 60 min, three times a week. Patients were randomly (1:1) toMICT
(n = 10) and HIIT (n = 12). Both training programs involved treadmill exercise. The group MICT at 75%
of peak heart rate (HR) and HIIT at≈95% of peak HR. Outcome measurements included an assessment of QoL
(Minnesota Living with Heart Failure Questionnaire (MLHFQ) and SF-36), measurements of 6-min walk test
(6MWT) and peak oxygen consumption (VO2 peak).
Results: Exercise was associated with a signiﬁcant increased of 6MWT in 19.4% and 23.1% fromMCIT and HIIT,
respectively (p b 0.001), but not between-group differences. It was observed an improvement in VO2 peak by
11.2% in the HIIT group and 8.3% in the MCIT group, with between-group differences (p b 0.01). Quality of life
improved signiﬁcantly and in all domains in both groups (p-value time-effect). All patients showed signiﬁcant
improvements in all domains from baseline, it was observed in both groups (p b 0.05), with between-group
differences for functional capacity (SF-36). No changes were observed in pain (SF-36) for both groups.
Conclusion: Both training programs were equally effective in improving QoL and functional capacity in
CHF patients.
Trial registration: (http://www.ensaiosclinicos.gov.br/): RBR-6hk9p6; registered on 15 May 2013.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Up to ﬁve million Americans over 20 years old have chronic heart
failure (CHF). Projections show that by 2030, the prevalence of CHF
will increasewith 25% from2013 [1]. CHF is a complex chronic condition
that results from any structural or functional impairment of ventricular
ﬁlling or ejection of blood [2]. One of the major central characteristics
of this condition is an imbalance of the cardiovascular system caused
by complex hemodynamic, anatomical, functional and biological
progressively worsening, thus creating a vicious cycle [3,4].
As a result, most heart failure patients experience symptoms as
shortness of breath and fatigue, which interfere with daily activitiesability and freedom from bias of
358 Coqueiros, Florianopolis,
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. This is an open access article underand often have a tremendous impact on the quality of life (QoL) [5,6].
The quality of life is much lower compared to healthy individuals and
other diseases [7]. Current guidelines for the treatment and manage-
ment of heart failure ﬁrmly recommend regular physical activity and
structured exercise training [8]. The major beneﬁts of this multidisci-
plinary approach include an enhancement in peripheral blood circula-
tion [9], as well as in skeletal muscle and functional capacity [10–13],
early return to routine, increased aerobic conditioning and signiﬁcant
beneﬁts in social life [14,15]. Moreover, exercise training, as an impor-
tant adjuvant part of this rehabilitation program, has been shown to im-
prove endothelial function and oxidative capacity of the skeletal muscle
[16,17], increase of peak oxygen consumption [16,18,19] and maximal
aerobic power and reduce neurohumoral exacerbation [12,15].
However, despite its proven effectiveness, the search for better
exercise modalities that ﬁt patients' taste better and are more likely to
improve adherence and hence clinical outcomes in heart failure patients
is still ongoing. As such, recent data have already shown that high inten-
sity interval training is superior to moderate continuous training forthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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patients [20]. However, less is known about the effect of this emerging
exercise intensity on the quality of life of these patients. The study
presented three components of the deﬁnition of quality of life self re-
ports by patients with heart failure, the being: performing physical
and social activities; maintaining happiness, and; engaging in fulﬁlling
relationships [21]. Based on these reports [21] and the effects of high-
intensity exercise found in the meta-analysis [22], the hypothesis of
our study is to show greater increases in scores for quality of life of
patients with HF submitted to HIIT compared to MCIT, also already
shown in a recent study [23]. Therefore, the aim of this pilot study
was to assess the potentials of HIIT to improve quality of life and
physical ﬁtness in patients with chronic heart failure.2. Methods
2.1. Study design and population
A randomized controlled double-blind trial was performed to
evaluate the effect of HIIT vsMICT on quality of life and physical ﬁtness
in CHF patients. Patients were recruited at the Divisions of Cardiology of
the public and private hospitals of Florianopolis, Santa Catarina State,
Brazil. Eligibility criteria were that participants should be: 1) male;
2) aged 40 yr or older; 3) with a resting left ventricular ejection fraction
under 40%; 4) peak oxygen uptake under 20ml·kg·min; 5) classiﬁed as
New York Heart Association class (NYHA) II–III who were clinically
stable and on optimal medical therapy for at least 30 days. In addition,
they should be free of physical or mental disabilities, which could
limit physical training. Patients were excluded if they presented with
unstable angina pectoris, uncompensated heart failure, primary pulmo-
nary hypertension, pulmonary infections or active pulmonary thrombo-
embolism, myocardial infarction in the past 4 weeks and complex
ventricular arrhythmias.
After obtainingwritten informed consent patients were randomized
to HIIT orMICT. The randomization code was generated by means of a
simple allotment to select random permuted blocks (Fig. 1).
The study was accomplished according to the World Medical
1975 Declaration of Helsinki on ethics in medical research [24]
and was approved by the local Research Ethics Committee of the
University of the State of Santa Catarina. The design and resultsFig. 1. Flow of study participof the study are registered in Clinical trials: RBR-6hk9p6 (http://
www.ensaiosclinicos.gov.br/).
2.2. Measurements
All measurements were performed at baseline and after the
12-week intervention period, i.e. two days after the last training session,
by blinded investigators. Assessments were done at the same time of
day for each individual patient.
2.2.1. 6-min walk test (6MWT)
The 6MWT was used to assess functional capacity [25]. After
informing the patients about the aim of the 6MWT, all patients
performed two 6MWT's with a 30 min rest period in between. Each
patient was instructed to cover the longest distance as possible in
6 min. They were told to walk continuously, however at their limits
they could slow down or stop, if necessary. The test was performed
by a blinded exercise physiologist who encouraged all patients in
a standardized fashion [26,27]. Outcome measure was the total
walking distance covered in 6 min. The Borg Score (0 to 10 scale)
was assessed at the end of the 6MWT [28].
2.2.2. Cardiopulmonary exercise test
Subsequently a maximal graded cardiopulmonary exercise test to
evaluate their exercise capacity by measuring VO2 (ml·kg−1·min−1),
until evolutional exhaustionwas performed according to ESC guidelines
[29] on a treadmill (Centurion 200 — Micromed; Brasília, DF, Brazil)
using a ramp protocol individually adjusted to last 8 to 12 min after
warm-up [30]. During the test, heart rate, a ﬁve-lead electrocardiogram
(Elite —Micromed; Brasília, DF — Brazil) and respiratory gas exchange
measurementswhichwas performed by using breath by breath analysis
(Metalyser 3B — Cortex Biophysik; Leipzig, Germany) were recorded
continuously. Blood pressure was measured by auscultatory method
[31] every 2-min, at the peak exercise and recovery. A leveling off of
oxygen uptake despite increased workload and a respiratory exchange
ratio higher than 1.05 were used as criteria for maximal oxygen uptake
[32]. VO2 peakwas deﬁne at the highest level of oxygen uptake achieved
during the last 30 s. Maximal Heart Rate (HR) at the end of the test
was set as the patients' maximum HR. Oxygen uptake in milliliters
per kilogram per minute at a ﬁxed submaximal work load deﬁnedants through the Trial.
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according to the manufacturer's instructions.
It used the procedures of the Statement on Cardiopulmonary
Exercise testing ATS/ACCP [33] for evaluation of the changes in VE/Vo2,
VE/VCO2, respiratory exchange ratio (RER) and expired PCO2 with
changes in VO2 associated with the work rate, ventilatory threshold
(VT) was identiﬁed as the VO2 point the transition of VE/VO2 from falling
to rising phases occurred before the transition of VE/VCO2 from falling to
rising phases, and that of expired PCO2 from increasing and the leveling
off to decreasing occurred. The VO2 point at which the latter two transi-
tions occurred was deﬁned as the respiratory compensation point
(RCP). First and second ventilatory thresholdswere recorded as an indi-
cation of aerobic and anaerobic thresholds, respectively. Anaerobic
threshold was deﬁned as 1) the point where the ventilatory equivalent
for O2 (VE/VO2) was minimally followed by a progressive increase;
2) the point after which the respiratory gas exchange ratio consistently
exceeded the resting respiratory gas exchange ratio; and 3) the VO2
after which a nonlinear increase in minute ventilation occurred relative
to VO2.
Finally, subjective feelings of exhaustion were assessed at the end of
the test by means of the 10-point Borg scale rating [34].
2.2.3. Echocardiography
All patients were examined at rest in the left lateral supine position
with a Vivid E portable (GE Vingmed Ultrasound, Horten, Norway)
scanner with B-mode ultrasound at a frame rate of 50 Hz. Left ventricle
chamber dimensions were evaluated using standard procedures
according to the recommendations of the American Society of
Echocardiography [35]. Left ventricle ejection fraction (LVEF) was
calculated from 2-dimensional apical images according to Simpson's
method [36].
2.2.4. Quality of Life (QoL)
Self-reported data on perceived QoLwere collected bymeans of two
questionnaires: the Minnesota Living with Heart Failure Questionnaire
(MLHFQ) [37] and the generic SF-36 health status survey (SF-36) [38].
MLHFQ is a disease-speciﬁc measure of quality of life in CHF patients,
which assesses patient perception of the degree to which CHF and its
treatment inﬂuences physical symptoms, physical and social functions
and psychological components of living. The total score is the sum of
the all items and the possible total score ranges from zero to 105. Higher
scores reﬂectworse quality of life. This questionnaire has been shown to
be valid. [39]. In addition, we used the Brazilian version of the 36-item
Short-Form Health Survey (SF-36) [38]. This generic instrument
consists of 36 questions divided into the following domains: physical
functioning, role-physical, pain, general health perception (ﬁve items),
vitality (four items), social functioning (two items), role-emotional
(three items), and mental health (ﬁve items). Each dimension is
individually analyzed and the scores of the eight components may
range from 0 to 100 to a ﬁnal score. Low scores indicate poor QoL. The
range of 0–20 represents a very bad QoL, 20–40 represents a bad QoL,
40–60 moderate, 60–80 good and optimal 80–100 [40].
2.2.5. Exercise training
All patients were exercising in the morning, three times a week for
12 weeks under individual supervision of an exercise physiologist. The
exercise protocol training was adapted of Wisloff et al. [41]. Exercise
training involved uphill treadmillwalking or running (Embrex, Brusque,
Santa Catarina — Brazil; model: 570-Pro). Both MICT and HIIT started
with a 7–10-min warm-up period at an intensity corresponding to
70% of peak heart rate (HR). Subsequently, patients randomized to the
MICT group continued to walk continuously for an additional 30 min
at an intensity of 75% of peak HR (corresponding to this ﬁrst ventilatory
threshold), without breathing heavily; the adapted perceptual scale of
physical effort was set to be equivalent from moderate to somewhat
hard [28]. Patients randomized to the HIIT group walked with intervalsof 3-min at intensity equivalent to ~95% of peak heart rate (at least
10% above of respiratory compensation point). Each interval was
interspersed by active recovery of 3-min, walking at 70% of peak HR.
The adapted perceptual scale of physical effort was set to be equivalent
to hard and very hard [28]. On average, patients randomized to HIIT
would perform 4–6 intervals. All training sessions for both MCT and
HIIT ended with a 5-min cool-down period at 50% of VO2 peak. This
represented a total exercise time for both groups of 60-min (10 min of
warm-up; 40min ofMICT or HIIT and 10min of cool down). All patients
exercised using a heart rate monitoring device (Polar Electro, Kempele,
Finland; model: RS800CX) and the velocity and inclination of the
treadmill were adjusted constantly to ensure that each training session
was carried out at the assigned intensity throughout the study period.
In addition, the adapted Borg 0-to-10 scale was used to assess the
subjective feelings of perceived exertion during and after each training
session [28].
Patients were instructed to immediately stop physical training
if they experienced chest pain or any other symptoms and were
asked to refrain from any extra exercise beyond the study period. No
symptoms were reported before, during or after training sessions.
2.2.6. Statistical analysis
Baseline characteristics of the study population are presented as
number (percentages) for categorical variables and asmeans± standard
deviation (SD) for continuous variables. Normality of the data was
checked by means of the Kolmogorov–Smirnov test. Both intragroup
and intergroup comparisons were performed using two-way repeated-
measures analysis of variance followed by the Tukey's post hoc test,
with report time, group and interaction effect. The differences in categor-
ical data were assessed by the Chi-squared test (χ2). To verify the
percentage differences between the beginning and the end of 12 weeks
of intervention, the Delta variation (Δ%) was used. All analyses were
performed using SPSS for Windows (version 18.0; SPSS, Chicago, IL).
All p values were 2-sided. A p-value (two-sided) ≤0.05 was considered
statistically signiﬁcant.
3. Results
A ﬂow chart of the trial is shown in Fig. 1. After checking the
medical records of the 367 cardiac patients at our department, 201
were excluded for not meeting the eligibility criteria. Of the remaining;
117 refused to participate, 19 incomplete screening packages and three
no physician approval by doctor. In the end, 27 CHF patients could be
randomized to MCIT (n = 12; mean age 54.0 ± 9.9) or HIIT (n = 15;
mean age 53.2 ± 7.0). Five patients dropped out during the study
due to: not completing a minimum of 80% of the exercise sessions
(oneHIIT and twoMCIT), lost interest (oneHIIT) and clinical decompen-
sation unrelated to the exercise training (one MCIT). Therefore, our
analyses are based on data from the remaining 22 CHF patients. There
were no adverse events related to exercise training reported during
the study.
Table 1 shows the baseline and demographic characteristics of the
included patients. At baseline, there were no signiﬁcant differences
between both intervention groups. CHF patients ranged in age from
41 to 71 years (mean age 54.08± 7.5 years). Most patients were public
hospital, classiﬁed in the lower and middle class, and were functioning
in NYHA II. The mean left LVEF was 33.99 ± 7.7%, average VO2 peak
averaged 20.46 ± 4.2 ml·kg−1·min−1. Medication remained
unchanged during the study.
As can be seen in Table 2, both groups showed a signiﬁcant
improvement on hemodynamics, in functional capacity and two
score questionnaires' of QoL.
Patients reported that a diversity of factors affected their QOL.
Further signiﬁcant favorable effects were seen on all dimensions
of QoL assessed by the speciﬁc (MLHFQ; Fig. 2) and general (SF-36;
Fig. 3) questionnaires following MICT and HIIT. Patients reported in
Table 1






Age (years) 54.02 ± 9.9 53.15 ± 7.0 0.231 0.820
Weight (kg) 81.03 ± 19.9 85.4 ± 17.1 −0.543 0.593
Height (cm) 170.73 ± 17.1 169.3 ± 8.8 0.415 0.683
BMI (kg/m2) 27.47 ± 4.6 29.73 ± 5.4 −1.047 0.307
Hemodynamics
Resting SBP (mm Hg) 113.63 ± 14.3 130.00 ± 25.5 −1.834 0.082⁎
Resting DBP (mm Hg) 73.9 ± 9.3 79.3 ± 12.8 −1.104 0.284
Resting HR (beats/min) 88.25 ± 24.9 84.80 ± 24.19 0.327 0.747
Functional class (NYHA) n(%)a
II 11 (50%) 10 (45.5%) 0.873 0.350
III 1 (4.5%) -
CHF etiology n(%)a
Ischaemic 8 (36.4%) 7 (31.8%) 0.028 0.867
Non-ischaemic 4 (18.2%) 3 (13.6%)
Socioeconomic status n(%)a
High/highest 1 (4.5%) 0 (0%) 0.917 0.632
Middle 6 (27.6%) 5 (22.7%)
Low/lowest 5 (22.7%) 5 (22.7%)
SUS patients n(%)a 11 (50%) 7 (31.8%) 1.721 0.190
Ethnic characteristics n(%)a
Caucasian 9 (40.9%) 8 (36.4%) 0.078 0.781
Concomitant diseases n(%)a
CAD 7 (31.8%) 5 (22.7%) 0.153 0.696
Hypertension 6 (27.3%) 8 (36.4%) 2.121 0.145
Diabetes – 2 (9.1%) 2.640 0.104
Dyslipidemia 1 (4.5%) 2 (9.1%) 0.630 0.427
Current smoking? 4 (18.2%) 7 (31.8%) 2.933 0.087
Overweight 5 (22.7%) 3 (13.6%) 1.497 0.473
Obesity 3 (13.6%) 5 (22.7%) 1.744 0.4367
Medication drugs during
follow-up n(%)a
ACE inhibitors 11 (50%) 8 (36.4%) 0.630 0.427
β-blockers 10 (45.5%) 10 (45.5%) 1.833 0.176
Digitalis 7 (38.8%) 5 (22.7%) 0.153 0.696
Diuretics 11 (50%) 9 (40.9%) 0.018 0.892
Nitrates 3 (13.6%) 3 (13.6%) 0.069 0.793
Anticoagulants 9 (40.9%) 5 (22.7%) 1.473 0.225
Antiarrhythmic 2 (9.1%) 1 (4.5%) 0.206 0.650
Statins 4 (18.2%) 7 (31.8%) 2.933 0.087
LVEF (%) 32.8 ± 7.7 35.40 ± 6.7 −0.793 0.439
VO2 peak (ml·kg−1·min−1) 18.39 ± 4.3 21.41 ± 4.1 −0.908 0.375
6MWT (m) 447.4 ± 60.3 456.6 ± 36.3 0.343 0.735
Values are reported as mean ± SD.
Abbreviations:HIIT: high-interval intensity training;MICT:moderate-intensity continuous
training; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood
pressure; HR: heart rate; NYHA: New York Heart Association; CHF: chronic heart
failure; SUS: Brazil's Uniﬁed Health System; LVEF: left ventricular ejection fraction;
VO2 peak: peak of oxygen consumption; 6MWT: six minute walk test; CAD: coronary
artery disease; ACE inhibitors: angiotensin-converting enzyme inhibitors.
a Chi-square test.
⁎ p b 0.05.
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of these factors improved in both groups, such as physical symptoms
(increased ~80%), general health (increased ~55%) and other changes,
with exception to the ﬁeld of pain (SF-36) that has not changed.
No signiﬁcant differences between both groups could be observed for
any of the domains (p-value for all N0.05).
4. Discussion
The results of this randomized trial demonstrate that 12 weeks of
high exercise training three times per week was as effective as moder-
ate intensity continuous training for improving QoL in stable CHF
patients. This research conﬁrms the beneﬁcial effects of exercise train-
ing in the management of heart failure [2,5,14,42,43], and shows thatboth programs can be used to improve QoL in this patients' population.
However, a recent position statement of the Heart Failure Association
and the European Association for Cardiovascular Prevention and
Rehabilitation recommends regular physical activity and structured ex-
ercise training in the cardiac rehabilitation programmers'. However, this
recommendation is still poorly implemented in daily clinical practice
outside specialized centers for CHF [8].
A recent review demonstrated that there is strong epidemiological
evidence on the beneﬁcial effects of regular exercise and can overcome
those of common drugs when one considers that the exercise is the real
polypill that combines preventive, multi-systemic effects with a little
adverse consequences and at lower cost [44], such evidences can be
observed in the present study. The authors add that the identiﬁcation
of exercise adaptations is helping to improve our understanding of the
pathophysiology of chronic diseases, especially the CHF, which could
help to investigate new approaches and therapeutic targets [44]. It
should be emphasized that CHF is a chronic and progressive syndrome,
in which lower QoL is associated to high rates of hospital readmission
and mortality [45,46], and in this study there were no complications.
Fletcher et al. [47] described that aerobic exercise is clearly beneﬁcial
in lowering mortality compared to a sedentary lifestyle. In current
statements of CHF there is a suggestion of three different training mo-
dalities (continuous endurance, interval endurance, resistance/strength,
and respiratory) in stable CHF patients. These training modalities have
been proposed with different combinations (different intensities),
according to exercise capacity and clinical characteristics [8]. In this
case, we proposed to test a hypothesis in this study, which high intensi-
ty exercise has higher impact at higher increases inQoLwhen compared
with moderate intensity. Unfortunately it was not conﬁrmed for all
domains, except for the physical domain of the SF-36 that relationship
to VO2 peak.
The distance in 6MWT and VO2 peak increased in both groups after
12 weeks of training, the improvement was signiﬁcantly superior in
the HIIT (p = 0.025). In our study we found a signiﬁcant increase
intragroup, HIIT and MCIT, respectively of 11.2% and 8.3% of VO2 peak,
23.1% and 19.4% in the 6MWT, and improvement in classes of functional
capacity, according to Weber [48]. However the two groups were not
associated with regard to the total amount of work performed, this
study points out high aerobic intensity as a key factor for increasing
functional capacity in this group. We highlight the Bittner et al. [26]
study, which had already demonstrated that the 6MWT distance
traveled is inversely related to mortality in patients with CHF who
walked less than 300 m had high risk of death. Nevertheless, in this
same study, the distances on the 6MWTwere assigned superiors' both
groups after intervention. In a meta-analysis, Piepoli et al. [49] also
described that exercise training signiﬁcantly reduced mortality in 35%
in interventions, mainly above 28 weeks. However, in our study we
found signiﬁcant differences in a shorter protocol, but with higher
intensity than the reported from Piepoli et al. [49]. The effects of higher
versus others (moderate and low) exercise intensity with regard to
increase capacity functional have been demonstrated in earlier studies
of systematic reviews [50–54].
Haykowsky et al. [53] complement that high intensity leads to signif-
icantly larger increases in VO2 peak compared with moderate intensity
(mean difference 2.14 ml·kg−1·min−1). The increase in VO2 peak
observed in this study can be explained according to systematic review
that report the improvements in oxygen uptake resulting from high-
intensity exercise were achieved through increases in maximal cardiac
output [55]. The study Wisløff et al. [41] was the ﬁrst study to demon-
strate the superior effects of high-intensity exercise. The major ﬁnding
was that high-intensity was superior to moderate-intensity in patients
with post-infarction heart failure with regard to reversal of left ventric-
ular remodeling, aerobic capacity, endothelial function, and QoL [41].
Preliminary studies [56,57] have shown that aerobic exercise
improves scores MLWHFQ in CHF patients, but higher than changes
have been reported due to the exercise of high intensity interval [41,58],
Table 2





Baseline 12 weeks follow-up Δ% p-Value Baseline 12 weeks follow-up Δ% p-Value p-Value⁎⁎
Hemodynamics
Resting SBP (mm Hg) 113.1 ± 13.7 105.0 ± 12.5 −8.2 0.065 130.0 ± 25.5 111.4 ± 15.5⁎ −16.3 0.004 0.305
Resting DBP (mm Hg) 73.7 ± 8.9 68.7 ± 8.5 −8.1 0.108 79.3 ± 12.8 71.9 ± 8.0⁎ −10.3 0.049 0.386
Resting HR (beats/min) 84.7 ± 12.8 71.8 ± 11.6⁎ −19.6 0.007 83.1 ± 19.1 75.4 ± 10.4 −12.0 0.295 0.463
LVEF (%) 32.8 ± 7.7 35.7 ± 11.3 8.12 0.369 35.4 ± 6.4 39.9 ± 8.8⁎ 9.7 0.013 0.315
Functional capacity
VO2 peak (ml·kg−1·min−1) 18.39 ± 4.3 20.23 ± 3.0⁎ 8.3% 0.041 21.41 ± 4.1 24.2 ± 4.6⁎,⁎⁎ 11.2% b0.001 0.003
6MWT (m) 464.0 ± 60.3 557.9 ± 56.9⁎ 19.4% b0.001 456.6 ± 36.3 596.3 ± 48.5⁎ 23.1% b0.001 0.954
MLHFQ
Physical dimension 13.9 ± 6.9 8.4 ± 5.9⁎ −110% 0.012 12.3 ± 9.9 7.8 ± 6.7⁎ −120% 0.027 0.967
Emotional dimension 9.4 ± 4.6 4.7 ± 3.6⁎ −320% 0.034 8.5 ± 7.1 5.1 ± 4.4⁎ −207% 0.017 0.767
Reminiscent questions 15.7 ± 3.9 8.1 ± 5.0⁎ −246% 0.008 12.8 ± 6.2 6.8 ± 5.0⁎ −266% 0.010 0.590
Total scale score 39.1 ± 12.1 20.8 ± 11.6⁎ −156% b0.001 33.5 ± 17.4 18.9 ± 14.7⁎ −289% 0.005 0.826
SF-36
Physical functioning 54.5 ± 18.6 74.1 ± 16.8⁎ 29.2% 0.020 69.0 ± 18.2 89.5 ± 7.6⁎,⁎⁎ 23.2% 0.009 0.025
Role-physical 16.6 ± 22.1 78.1 ± 23.9⁎ 80.1% b0.001 20.0 ± 28.3 75.0 ± 23.5⁎ 77.5% b0.001 0.543
Bodily pain 62.1 ± 18.2 65.5 ± 15.6 1.7% 0.557 53.9 ± 19.9 57.7 ± 15.6 2.9% 0.613 0.220
General Health 5.0 ± 4.7 13.2 ± 5.7⁎ 53.8% 0.010 8.5 ± 6.8 14.9 ± 3.0⁎ 47.1% 0.007 0.642
Vitality 50.8 ± 20.5 70.4 ± 14.5⁎ 26.5% 0.015 57.5 ± 22.6 78.5 ± 14.7⁎ 26.5% 0.008 0.668
Social functioning 56.2 ± 18.1 94.7 ± 9.9⁎ 40.8% 0.001 67.5 ± 25.1 90.0 ± 14.9⁎ 26.7% 0.002 0.500
Role-emotional 61.1 ± 23.0 90.6 ± 20.5⁎ 23.5% 0.012 79.4 ± 18.1 96.6 ± 10.5⁎ 18.1% 0.005 0.114
Mental health 66.0 ± 25.3 81.3 ± 19.1⁎ 18.6% 0.033 69.8 ± 239 81.2 ± 17.3⁎ 16.6% 0.002 0.787
SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; LVEF: left ventricular ejection fraction; VO2 peak: peak of oxygen uptake; 6MWT: sixminuteswalk test;MLHFQ:
Minnesota Living with Heart Failure Questionnaire; SF-36: Long Form 36 Health Survey;WRpeak: limit of tolerance. Footnotes indicate signiﬁcant changes. Values in mean ± SD.
⁎ From baseline to 12 weeks (p b 0.05) within groups.
⁎⁎ From 12 weeks to 12 weeks (p b 0.05) between groups.
25A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 21–28whichmight explain themajorﬁndings in our study.Morgan et al. [5] also
in a systematic review emphasized the innovation of CHF treatment by
means of primary and secondary interventions, in order to maintain andFig. 2.Quality of life (MLHFQ) evaluated by themultiple domain questionnaires both before and
after) (p b 0.05). (p b 0.05) Abbreviations:MICT: moderate-intensity continuous training; HIITimprove the clinical conditions associated with QoL of these patients, de-
creasing dyspnea, fatigue, and palpitations that these patients feel to per-
form daily activities. So, the exercise is also recognized in full cardiacafter 12weeks of exercise training. Signiﬁcant differences between themoments (before vs
: high-interval intensity training.
Fig. 3. Quality of life (SF-36) evaluated by themultiple domain questionnaires both before and after 12weeks of exercise training. Signiﬁcant differences between themoments (before vs
after) (p b 0.05). (p b 0.05) Abbreviations:MICT: moderate-intensity continuous training; HIIT: high-interval intensity training.
26 A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 21–28rehabilitation in heart failure [8]. Carvalho et al. [59] ensure that the best
physical, psychological and social conditions, as seen in this study with
increasing CF and QoL and after intervention. Corroborating, Belardinelli
et al. [60] using theMLWHFQ and Gianuzzi et al. [61], themodiﬁed Likert
instrument, show an improvement in QoL in CHF patients associated
with exercise capacity and clinical improvement [62]. On the other
hand, studies were able to demonstrate improvement in QoL without
necessarily having an increase in exercise tolerance [63,64], or even a
weak association between these two variables [43,65]. With reduced
physical symptoms through exercise seen in the present study, no sucheffect affects the aggravation of this syndrome, which in turn improves
the emotional state which is evidently insecurity, independence, fear,
and sadness [5,64,66,67]. Recent ﬁndings [68] in patients with CHF al-
ready belonging to the rehabilitation program situation, demonstrate
having greater functional capacity, and lower QoL scores (good QoL) in
all areas when compared to beginners in rehabilitation programs.
Which may indicate involvement of these questions for the subjects
who didn't participate rehabilitation program.
On the other hand, understanding QoL often reﬂects the discrepancy
between the state of health perception of the patient's at themoment. It
27A.Z. Ulbrich et al. / Clinical Trials and Regulatory Science in Cardiology 13 (2016) 21–28was evident in our results the perception of improvement in both
groups, independent of exercise intensity. This in turn conﬁrms the
objective of rehabilitation, full improvement of these patients and the
real beneﬁts of the program [69]. We recognize the limitations in our
study. Our study should be interpreted in few or many limitations. The
research was accomplished at only one local, only with men, and was
limited to a relatively mean age of 53 years with CHF patients. The
exercise intensity was based on heart rate acquired by the ergometric
test. The rationale for using heart rate for guiding exercise intensity in
CHF is based on the relatively linear relationship between heart rate
and VO2 peak in exercise training programs [47]. However, an exercise
training prescription based only on heart rate peak has been shown to
overestimate exercise intensity [8,47]. The exercise sessions between
the groups in terms of intensity, time and workload they could be also
considered limiting factors. The resultsmay be generalizable to patients
with CHF. Aging is associated with increasing comorbidities and
worsening heart failure. Another concern could be that the differing dis-
tribution of the etiologies among the groups could inﬂuence the results.
5. Conclusion
Summarizing, our results demonstrate that independently of exer-
cise intensity in patients with CHF results in a signiﬁcant improvement
in QoL. It also shows that the high intensity of exercise may be an
important factor for improving aerobic capacity, in patients with CHF.
Meanwhile, our data also support the concept that exercise training
must be part of a heart failure treatment plan. However, loopholes re-
garding optimal training protocol remain unanswered. These ﬁndings
represent a vital implication for rehabilitation programs designated to
CHF patients. Although exercise intervention is an attractive strategy
for enhances of CHF, strategies for maintaining patient compliance to
the training programwould be necessary. In view of the prognostic im-
portance of increasing functional capacity and QoL for this patient
group, high intensity exercisemay be considered in future rehabilitation
programs.We assume that the differential of the rehabilitation program
be extra-hospital might have substantially contributed to the improve-
ment of social and psychological life, however, more research must be
conducted in order to conﬁrm our ﬁndings.
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